Trial of TG4023 Combined With Flucytosine in Liver Tumors
NCT00978107
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
BIOLOGICAL:
MVA-FCU1, flucytosine
Sponsor
Transgene